Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James Chipeta is active.

Publication


Featured researches published by James Chipeta.


PLOS ONE | 2014

Pediatric Malignancies, Treatment Outcomes and Abandonment of Pediatric Cancer Treatment in Zambia

Jeremy S. Slone; Catherine Chunda-Liyoka; Marta Perez; Nora Mutalima; Robert Newton; Chifumbe Chintu; Chipepo Kankasa; James Chipeta; Douglas C. Heimburger; Sten H. Vermund; Debra L. Friedman

Background There exist significant challenges to the receipt of comprehensive oncologic treatment for children diagnosed with cancer in sub-Saharan Africa. To better define those challenges, we investigated treatment outcomes and risk factors for treatment abandonment in a cohort of children diagnosed with cancer at the University Teaching Hospital (UTH), the site of the only pediatric oncology ward in Zambia. Methods Using an established database, a retrospective cohort study was conducted of children aged 0–15 years admitted to the pediatric oncology ward between July 2008 and June 2010 with suspected cancer. Diagnosis, mode of diagnosis, treatment outcome, and risk factors for abandonment of treatment were abstracted from this database and clinical medical records. Results Among 162 children treated at the UTH during the study time period that met inclusion criteria, only 8.0% completed a treatment regimen with most of the patients dying during treatment or abandoning care. In multivariable analysis, shorter distance from home to the UTH was associated with a lower risk of treatment abandonment (Adjusted Odds Ratio [aOR] = 0.48 (95% confidence interval [CI] 0.23–0.97). Conversely maternal education less than secondary school was associated with increased risk for abandonment (aOR = 1.65; 95% CI 1.05–2.58). Conclusions Despite availability of dedicated pediatric oncology treatment, treatment completion rates are poor, due in part to the logistical challenges faced by families, low educational status, and significant distance from the hospital. Alternative treatment delivery strategies are required to bring effective pediatric oncology care to the patients in need, as their ability to come to and remain at a central tertiary care facility for treatment is limited. We suggest that the extensive system now in place in most of sub-Saharan Africa that sustains life-long antiretroviral therapy for children with human immunodeficiency virus (HIV) infection be adapted for pediatric cancer treatment to improve outcome.


Acta Tropica | 2012

Malaria epidemiology and control in Southern Africa.

Sungano Mharakurwa; Philip E. Thuma; Douglas E. Norris; Modest Mulenga; Victor Chalwe; James Chipeta; Shungu Munyati; Susan Mutambu; Peter R. Mason

The burden of malaria has decreased dramatically within the past several years in parts of sub-Saharan Africa, following the scale-up of interventions supported by the Roll Back Malaria Partnership, the Presidents Malaria Initiative and other partners. It is important to appreciate that the reductions in malaria have not been uniform between and within countries, with some areas experiencing resurgence instead. Furthermore, while interventions have greatly reduced the burden of malaria in many countries, it is also recognized that the malaria decline pre-dated widespread intervention efforts, at least in some cases where data are available. This raises more questions as what other factors may have been contributing to the reduction in malaria transmission and to what extent. The International Center of Excellence for Malaria Research (ICEMR) in Southern Africa aims to better understand the underlying malaria epidemiology, vector ecology and parasite genomics using three contrasting settings of malaria transmission in Zambia and Zimbabwe: an area of successful malaria control, an area of resurgent malaria and an area where interventions have not been effective. The Southern Africa ICEMR will capitalize on the opportunity to investigate the complexities of malaria transmission while adapting to intervention and establish the evidence-base to guide effective and sustainable malaria intervention strategies. Key approaches to attain this goal for the region will include close collaboration with national malaria control programs and contribution to capacity building at the individual, institutional and national levels.


Acta Tropica | 2012

Challenges and prospects for malaria elimination in the Southern Africa region.

William J. Moss; Douglas E. Norris; Sungano Mharakurwa; Alan F. Scott; Modest Mulenga; Peter R. Mason; James Chipeta; Philip E. Thuma

The burden of malaria has decreased dramatically within the past several years in parts of sub-Saharan Africa, including regions of Southern Africa. Important to effective regional malaria control in Southern Africa is the appreciation that the reductions in malaria have not been achieved uniformly, with some countries experiencing resurgence. Understanding the reasons for sustained low-level malaria transmission in the face of control efforts, why malaria control efforts have not been successful in particular epidemiological settings and the epidemiological and transmission patterns following resurgence are critical to improving further malaria control and possible elimination. The overall goal of the International Center of Excellence for Malaria Research in Southern Africa is to contribute to regional malaria control efforts that can be sustained beyond the duration of the project. This goal will be achieved through a combination of: (1) state-of-the-art research on malaria epidemiology, vector biology and the genetics of the malaria parasite in three different epidemiological settings; (2) collaborations with national malaria control programs to develop locally adapted and sustainable control strategies; and (3) training, career development and capacity building at research institutions throughout the region.


Clinical Infectious Diseases | 2017

Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study

Nicholas Fancourt; Maria Deloria Knoll; Henry C. Baggett; W. Abdullah Brooks; Daniel R. Feikin; Laura L. Hammitt; Stephen R. C. Howie; Karen L. Kotloff; Orin S. Levine; Shabir A. Madhi; David R. Murdoch; J. Anthony G. Scott; Donald M. Thea; Juliet O. Awori; Breanna Barger-Kamate; James Chipeta; Andrea N. DeLuca; Mahamadou Diallo; Amanda J. Driscoll; Bernard E. Ebruke; Melissa M. Higdon; Yasmin Jahan; Ruth A. Karron; Nasreen Mahomed; David P. Moore; Kamrun Nahar; Sathapana Naorat; Micah Silaba Ominde; Daniel E. Park; Christine Prosperi

Summary In the Pneumonia Etiology Research for Child Health study, abnormal chest radiographs (CXRs) in cases were associated with hypoxemia, crackles, tachypnea, and fever. Overall, 54% of CXRs were abnormal (site range, 35%–64%). Consolidation on CXR was associated with an increased risk of mortality.


Clinical Infectious Diseases | 2017

Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study

Henry C. Baggett; Nora L. Watson; Maria Deloria Knoll; W. Abdullah Brooks; Daniel R. Feikin; Laura L. Hammitt; Stephen R. C. Howie; Karen L. Kotloff; Orin S. Levine; Shabir A. Madhi; David R. Murdoch; J. Anthony G. Scott; Donald M. Thea; Martin Antonio; Juliet O. Awori; Vicky L. Baillie; Andrea N. DeLuca; Amanda J. Driscoll; Julie Duncan; Bernard E. Ebruke; Doli Goswami; Melissa M. Higdon; Ruth A. Karron; David P. Moore; Susan C. Morpeth; Justin M. Mulindwa; Daniel E. Park; Wantana Paveenkittiporn; Barameht Piralam; Christine Prosperi

Upper airway pneumococcal colonization density among children hospitalized with World Health Organization–defined pneumonia was associated with microbiologically confirmed pneumococcal pneumonia (MCPP). The optimal colonization density threshold for discriminating MCPP from non-MCPP was ≥7 log10 copies/mL (sensitivity, 64.3%, specificity, 92.2%).


Clinical Infectious Diseases | 2017

Standardization of Clinical Assessment and Sample Collection Across All PERCH Study Sites

Jane Crawley; Christine Prosperi; Henry C. Baggett; W. Abdullah Brooks; Maria Deloria Knoll; Laura L. Hammitt; Stephen R. C. Howie; Karen L. Kotloff; Orin S. Levine; Shabir A. Madhi; David R. Murdoch; Katherine L. O’Brien; Donald M. Thea; Juliet O. Awori; Charatdao Bunthi; Andrea N. DeLuca; Amanda J. Driscoll; Bernard E. Ebruke; Doli Goswami; Melissa M. Hidgon; Ruth A. Karron; Sidi Kazungu; Nana Kourouma; Grant Mackenzie; David P. Moore; Azwifari Mudau; Magdalene Mwale; Kamrun Nahar; Daniel E. Park; Barameht Piralam

Abstract Background. Variable adherence to standardized case definitions, clinical procedures, specimen collection techniques, and laboratory methods has complicated the interpretation of previous multicenter pneumonia etiology studies. To circumvent these problems, a program of clinical standardization was embedded in the Pneumonia Etiology Research for Child Health (PERCH) study. Methods. Between March 2011 and August 2013, standardized training on the PERCH case definition, clinical procedures, and collection of laboratory specimens was delivered to 331 clinical staff at 9 study sites in 7 countries (The Gambia, Kenya, Mali, South Africa, Zambia, Thailand, and Bangladesh), through 32 on-site courses and a training website. Staff competency was assessed throughout 24 months of enrollment with multiple-choice question (MCQ) examinations, a video quiz, and checklist evaluations of practical skills. Results. MCQ evaluation was confined to 158 clinical staff members who enrolled PERCH cases and controls, with scores obtained for >86% of eligible staff at each time-point. Median scores after baseline training were ≥80%, and improved by 10 percentage points with refresher training, with no significant intersite differences. Percentage agreement with the clinical trainer on the presence or absence of clinical signs on video clips was high (≥89%), with interobserver concordance being substantial to high (AC1 statistic, 0.62–0.82) for 5 of 6 signs assessed. Staff attained median scores of >90% in checklist evaluations of practical skills. Conclusions. Satisfactory clinical standardization was achieved within and across all PERCH sites, providing reassurance that any etiological or clinical differences observed across the study sites are true differences, and not attributable to differences in application of the clinical case definition, interpretation of clinical signs, or in techniques used for clinical measurements or specimen collection.


Clinical Infectious Diseases | 2017

Is Higher Viral Load in the Upper Respiratory Tract Associated With Severe Pneumonia? Findings From the PERCH Study

Daniel R. Feikin; Wei Fu; Daniel E. Park; Qiyuan Shi; Melissa M. Higdon; Henry C. Baggett; W. Abdullah Brooks; Maria Deloria Knoll; Laura L. Hammitt; Stephen R. C. Howie; Karen L. Kotloff; Orin S. Levine; Shabir A. Madhi; J. Anthony G. Scott; Donald M. Thea; Peter V. Adrian; Martin Antonio; Juliet O. Awori; Vicky L. Baillie; Andrea N. DeLuca; Amanda J. Driscoll; Bernard E. Ebruke; Doli Goswami; Ruth A. Karron; Mengying Li; Susan C. Morpeth; John Mwaba; James Mwansa; Christine Prosperi; Pongpun Sawatwong

Abstract Background. The etiologic inference of identifying a pathogen in the upper respiratory tract (URT) of children with pneumonia is unclear. To determine if viral load could provide evidence of causality of pneumonia, we compared viral load in the URT of children with World Health Organization–defined severe and very severe pneumonia and age-matched community controls. Methods. In the 9 developing country sites, nasopharyngeal/oropharyngeal swabs from children with and without pneumonia were tested using quantitative real-time polymerase chain reaction for 17 viruses. The association of viral load with case status was evaluated using logistic regression. Receiver operating characteristic (ROC) curves were constructed to determine optimal discriminatory viral load cutoffs. Viral load density distributions were plotted. Results. The mean viral load was higher in cases than controls for 7 viruses. However, there was substantial overlap in viral load distribution of cases and controls for all viruses. ROC curves to determine the optimal viral load cutoff produced an area under the curve of <0.80 for all viruses, suggesting poor to fair discrimination between cases and controls. Fatal and very severe pneumonia cases did not have higher viral load than less severe cases for most viruses. Conclusions. Although we found higher viral loads among pneumonia cases than controls for some viruses, the utility in using viral load of URT specimens to define viral pneumonia was equivocal. Our analysis was limited by lack of a gold standard for viral pneumonia.


Clinical Infectious Diseases | 2017

Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study

David R. Murdoch; Susan C. Morpeth; Laura L. Hammitt; Amanda J. Driscoll; Nora L. Watson; Henry C. Baggett; W. Abdullah Brooks; Maria Deloria Knoll; Daniel R. Feikin; Karen L. Kotloff; Orin S. Levine; Shabir A. Madhi; Katherine L. O’Brien; J. Anthony G. Scott; Donald M. Thea; Dilruba Ahmed; Juliet O. Awori; Andrea N. DeLuca; Bernard E. Ebruke; Melissa M. Higdon; Possawat Jorakate; Ruth A. Karron; Sidi Kazungu; Geoffrey Kwenda; Lokman Hossain; Sirirat Makprasert; David P. Moore; Azwifarwi Mudau; John Mwaba; Sandra Panchalingam

Abstract Background. It is standard practice for laboratories to assess the cellular quality of expectorated sputum specimens to check that they originated from the lower respiratory tract. The presence of low numbers of squamous epithelial cells (SECs) and high numbers of polymorphonuclear (PMN) cells are regarded as indicative of a lower respiratory tract specimen. However, these quality ratings have never been evaluated for induced sputum specimens from children with suspected pneumonia. Methods. We evaluated induced sputum Gram stain smears and cultures from hospitalized children aged 1–59 months enrolled in a large study of community-acquired pneumonia. We hypothesized that a specimen representative of the lower respiratory tract will contain smaller quantities of oropharyngeal flora and be more likely to have a predominance of potential pathogens compared to a specimen containing mainly saliva. The prevalence of potential pathogens cultured from induced sputum specimens and quantity of oropharyngeal flora were compared for different quantities of SECs and PMNs. Results. Of 3772 induced sputum specimens, 2608 (69%) had <10 SECs per low-power field (LPF) and 2350 (62%) had >25 PMNs per LPF, measures traditionally associated with specimens from the lower respiratory tract in adults. Using isolation of low quantities of oropharyngeal flora and higher prevalence of potential pathogens as markers of higher quality, <10 SECs per LPF (but not >25 PMNs per LPF) was the microscopic variable most associated with high quality of induced sputum. Conclusions. Quantity of SECs may be a useful quality measure of induced sputum from young children with pneumonia.


Clinical Infectious Diseases | 2017

The Effect of Antibiotic Exposure and Specimen Volume on the Detection of Bacterial Pathogens in Children With Pneumonia

Amanda J. Driscoll; Maria Deloria Knoll; Laura L. Hammitt; Henry C. Baggett; W. Abdullah Brooks; Daniel R. Feikin; Karen L. Kotloff; Orin S. Levine; Shabir A. Madhi; Katherine L. O’Brien; J. Anthony G. Scott; Donald M. Thea; Stephen R. C. Howie; Peter V. Adrian; Dilruba Ahmed; Andrea N. DeLuca; Bernard E. Ebruke; Caroline W. Gitahi; Melissa M. Higdon; Anek Kaewpan; Angela Karani; Ruth A. Karron; Razib Mazumder; Jessica McLellan; David P. Moore; Lawrence Mwananyanda; Daniel E. Park; Christine Prosperi; Julia Rhodes; Saifullah

Abstract Background. Antibiotic exposure and specimen volume are known to affect pathogen detection by culture. Here we assess their effects on bacterial pathogen detection by both culture and polymerase chain reaction (PCR) in children. Methods. PERCH (Pneumonia Etiology Research for Child Health) is a case-control study of pneumonia in children aged 1–59 months investigating pathogens in blood, nasopharyngeal/oropharyngeal (NP/OP) swabs, and induced sputum by culture and PCR. Antibiotic exposure was ascertained by serum bioassay, and for cases, by a record of antibiotic treatment prior to specimen collection. Inoculated blood culture bottles were weighed to estimate volume. Results. Antibiotic exposure ranged by specimen type from 43.5% to 81.7% in 4223 cases and was detected in 2.3% of 4863 controls. Antibiotics were associated with a 45% reduction in blood culture yield and approximately 20% reduction in yield from induced sputum culture. Reduction in yield of Streptococcus pneumoniae from NP culture was approximately 30% in cases and approximately 32% in controls. Several bacteria had significant but marginal reductions (by 5%–7%) in detection by PCR in NP/OP swabs from both cases and controls, with the exception of S. pneumoniae in exposed controls, which was detected 25% less frequently compared to nonexposed controls. Bacterial detection in induced sputum by PCR decreased 7% for exposed compared to nonexposed cases. For every additional 1 mL of blood culture specimen collected, microbial yield increased 0.51% (95% confidence interval, 0.47%–0.54%), from 2% when volume was ≤1 mL to approximately 6% for ≥3 mL. Conclusions. Antibiotic exposure and blood culture volume affect detection of bacterial pathogens in children with pneumonia and should be accounted for in studies of etiology and in clinical management.


Clinical Infectious Diseases | 2016

Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study

Breanna Barger-Kamate; Maria Deloria Knoll; E. Wangeci Kagucia; Christine Prosperi; Henry C. Baggett; W. Abdullah Brooks; Daniel R. Feikin; Laura L. Hammitt; Stephen R. C. Howie; Orin S. Levine; Shabir A. Madhi; J. Anthony G. Scott; Donald M. Thea; Tussanee Amornintapichet; Trevor P. Anderson; Juliet O. Awori; Vicky L. Baillie; James Chipeta; Andrea N. DeLuca; Amanda J. Driscoll; Doli Goswami; Melissa M. Higdon; Lokman Hossain; Ruth A. Karron; Susan A. Maloney; David P. Moore; Susan C. Morpeth; Lawrence Mwananyanda; Ogochukwu Ofordile; Emmanuel Olutunde

Background. Few data exist describing pertussis epidemiology among infants and children in low- and middle-income countries to guide preventive strategies. Methods. Children 1–59 months of age hospitalized with World Health Organization–defined severe or very severe pneumonia in 7 African and Asian countries and similarly aged community controls were enrolled in the Pneumonia Etiology Research for Child Health study. They underwent a standardized clinical evaluation and provided nasopharyngeal and oropharyngeal swabs and induced sputum (cases only) for Bordetella pertussis polymerase chain reaction. Risk factors and pertussis-associated clinical findings were identified. Results. Bordetella pertussis was detected in 53 of 4200 (1.3%) cases and 11 of 5196 (0.2%) controls. In the age stratum 1–5 months, 40 (2.3% of 1721) cases were positive, all from African sites, as were 8 (0.5% of 1617) controls. Pertussis-positive African cases 1–5 months old, compared to controls, were more often human immunodeficiency virus (HIV) uninfected-exposed (adjusted odds ratio [aOR], 2.2), unvaccinated (aOR, 3.7), underweight (aOR, 6.3), and too young to be immunized (aOR, 16.1) (all P ≤ .05). Compared with pertussis-negative African cases in this age group, pertussis-positive cases were younger, more likely to vomit (aOR, 2.6), to cough ≥14 days (aOR, 6.3), to have leukocyte counts >20 000 cells/µL (aOR, 4.6), and to have lymphocyte counts >10 000 cells/µL (aOR, 7.2) (all P ≤ .05). The case fatality ratio of pertussis-infected pneumonia cases 1–5 months of age was 12.5% (95% confidence interval, 4.2%–26.8%; 5/40); pertussis was identified in 3.7% of 137 in-hospital deaths among African cases in this age group. Conclusions. In the postneonatal period, pertussis causes a small fraction of hospitalized pneumonia cases and deaths; however, case fatality is substantial. The propensity to infect unvaccinated infants and those at risk for insufficient immunity (too young to be vaccinated, premature, HIV-infected/exposed) suggests that the role for maternal vaccination should be considered along with efforts to reduce exposure to risk factors and to optimize childhood pertussis vaccination coverage.

Collaboration


Dive into the James Chipeta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ruth A. Karron

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Henry C. Baggett

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge